Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage — Stella

Home/Pituitary Tumor/

View on ClinicalTrials.gov

Recruiting

Back to Pituitary Tumor trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Taiwan

National Taiwan University Hospital, Taipei

Key details

Sponsor

National Taiwan University Hospital

Enrollment target

~30 participants

Started

December 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years and older

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.